Back

AV nodal blocking therapy in AF: when, how and for whom?

5 April 2022 (08:30 - 08:42)
Organised by:
Congress Presentation Part of: Is there still room for drugs to control atrioventricular nodal conduction in atrial fibrillation (AF)? Atrial Fibrillation (AF) EHRA Premium Access EHRA 2022

About the speaker

Photo
Professor Serge Boveda

Clinic Pasteur, Toulouse (France)

4 More presentations in this session

Presentation thumbnail
The role of digoxin in atrial fibrillation.
Professor P. Kirchhof (Hamburg, DE)
Slides Video
Presentation thumbnail
The role of a calcium channel blocker in atrial fibrillation.
Doctor R. Tieleman (Groningen, NL)
Slides Video
Presentation thumbnail
Ablate and pace: the preferred therapy now?
Professor P. Vardas (Heraklion, GR)
Slides Video
Presentation thumbnail
Is there still room for drugs to control AV nodal conduction in AF? - discussion.
Video

Access the full session

Session thumbnail
Is there still room for drugs to control atrioventricular nodal conduction in atrial fibrillation (AF)?
Video

The Event

Event poster

EHRA 2022

5 April 2022 08:30 CET
You may be interested in
thumbnail
Congress Presentation
The role of rate control in heart failure with atrial fibrillation
thumbnail
Congress Presentation
Rate or rhythm control?
thumbnail
Congress Presentation
Rhythm control in HFrEF: drugs? atrial fibrillation ablation? or ablate and pace?

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources